Tanke Biosciences Corp
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
About Tanke Biosciences
Grain Mill Products, SIC 2040
Tanke Biosciences Corporation develops, manufactures, and supplies animal nutrition products and feed additives. Its primary product lines include organic trace mineral additives, feed acidifiers, flavor enhancers and seasonings, and herbal medicinal additives, as well as water-soluble multi-vitamin electrolytes. These nutritional products are formulated to support the growth and health of livestock, such as swine, poultry, and cattle, in addition to farmed fish and seafood. The company serves major feed manufacturers, large-scale commercial farming operations, and smaller agricultural farms through regional and local distribution partners.
The company operates in China, where it maintains its principal executive offices in Guangzhou. Its physical facilities include a 34,000 square-meter production plant in the Huadu Economic District of Guangzhou City within Guangdong Province. It markets twenty-six distinct brands of feed additives, with an average manufacturing capacity of about 560 metric tons per week. The company supplies its products across an extensive domestic network that covers China's ten largest feed producers and five hundred largest livestock farming operations.
Summary of the business section of Tanke Biosciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Tanke Biosciences Corp
- Founded
- 1989
- Headquarters
- Pearl River New City Guangzhou, F4
- Address
- Room 2801, East Tower Of Hui Hao Bldg, No. 519 Machang Road 510627
- Phone
- 86-20-38859025
- Employees
- 130, Dec 31, 2012
- Industry
- Grain Mill Products
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- TNBI
- Exchange
- OTC
- IPO date
- May 11, 2012
- Shares outstanding
- 13M, Nov 14, 2013
- Public float
- $1.68M, Jun 30, 2012
- SEC CIK
- 1452011
- EIN
- 26-3853855
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Tanke Biosciences's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“As of March 2013, we employed 130 full-time personnel.”
Corporate history
Events identified from SEC filings